We are live on ! Find out more
SCA

Stonebridge Capital Advisors Portfolio holdings

AUM $1.43B
1-Year Est. Return 21.98%
This Fund
S&P 500
This Quarter Est. Return
+2.92%
1 Year Est. Return
+21.98%
3 Year Est. Return
+64.22%
5 Year Est. Return
+80.67%
10 Year Est. Return
+293.7%
AUM
$381M
AUM Growth
+$13.6M
Cap. Flow
+$4.85M
Cap. Flow %
1.27%
Top 10 Hldgs %
24.21%
Holding
169
New
8
Increased
78
Reduced
44
Closed
5

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$3.56M
2
MSFT icon
Microsoft
MSFT
+$2.27M
3
IVV icon
iShares Core S&P 500 ETF
IVV
+$723K
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$384K
5
TFC icon
Truist Financial
TFC
+$364K

Top Sells

Rank Stock Value
1
UN
Unilever NV New York Registry Shares
UN
+$3.99M
2
GLW icon
Corning
GLW
+$3.12M
3
AAPL icon
Apple
AAPL
+$1.24M
4
BMS
Bemis
BMS
+$225K
5
BAX icon
Baxter International
BAX
+$218K

Sector Composition

Rank Sector Weight
1 Financials 15.18%
2 Healthcare 14.47%
3 Consumer Discretionary 11.78%
4 Consumer Staples 11.62%
5 Industrials 11.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INTC icon
51
Intel
INTC
$466B
$3.32M 0.87%
98,316
+3,826
+4% +$137K
LH icon
52
Labcorp
LH
$24.3B
$3.06M 0.8%
23,111
+116
+0.5% +$14.2K
TJX icon
53
TJX Companies
TJX
$170B
$3.03M 0.8%
84,028
+2,494
+3% +$94K
AGN
54
DELISTED
Allergan plc
AGN
$2.77M 0.73%
11,413
+155
+1% +$36.4K
ETN icon
55
Eaton
ETN
$157B
$2.77M 0.73%
35,631
-700
-2% -$53.3K
ELV icon
56
Elevance Health
ELV
$81.9B
$2.75M 0.72%
14,600
-520
-3% -$93.4K
EXC icon
57
Exelon
EXC
$48.6B
$2.53M 0.66%
98,335
+7,410
+8% +$189K
T icon
58
AT&T
T
$165B
$2.5M 0.66%
87,571
+8,541
+11% +$252K
CSCO icon
59
Cisco
CSCO
$450B
$2.39M 0.63%
76,376
+5,438
+8% +$177K
IWP icon
60
iShares Russell Mid-Cap Growth ETF
IWP
$20B
$2.39M 0.63%
44,256
+2,730
+7% +$145K
BP icon
61
BP
BP
$113B
$2.35M 0.62%
76,469
+4,089
+6% +$127K
MU icon
62
Micron Technology
MU
$1.04T
$2.13M 0.56%
71,390
+865
+1% +$25.3K
NVS icon
63
Novartis
NVS
$295B
$2.11M 0.55%
28,260
+632
+2% +$44.8K
SRE icon
64
Sempra
SRE
$60.8B
$2.05M 0.54%
36,350
– –
RTN
65
DELISTED
Raytheon Company
RTN
$2M 0.53%
12,389
+335
+3% +$53.1K
PEP icon
66
PepsiCo
PEP
$186B
$1.99M 0.52%
17,187
-197
-1% -$22.6K
TGT icon
67
Target
TGT
$62.1B
$1.96M 0.52%
37,529
+1,744
+5% +$95.3K
PFE icon
68
Pfizer
PFE
$140B
$1.93M 0.51%
60,672
+1,836
+3% +$57.9K
GOOG icon
69
Alphabet (Google) Class C
GOOG
$3.9T
$1.89M 0.5%
41,640
-260
-0.6% -$11.9K
SBUX icon
70
Starbucks
SBUX
$118B
$1.8M 0.47%
30,919
-160
-0.5% -$9.68K
STZ icon
71
Constellation Brands
STZ
$22.2B
$1.8M 0.47%
9,300
-110
-1% -$19.6K
DD
72
DELISTED
Du Pont De Nemours E I
DD
$1.78M 0.47%
22,030
+501
+2% +$40K
SCHW
73
Charles Schwab
SCHW
$177B
$1.75M 0.46%
40,770
-945
-2% -$37.8K
ENB icon
74
Enbridge
ENB
$124B
$1.68M 0.44%
42,203
-192
-0.5% -$7.73K
SYY icon
75
Sysco
SYY
$39.7B
$1.61M 0.42%
31,935
+643
+2% +$34.3K
1 2
3
4 5

Similar funds

SMA
Sage Mountain Advisors Atlanta, Georgia $1.43B AUM 16.47% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.43B AUM 22.07% 1-Year Est. Return
TS
Triglav Skladi Ljubljana, Slovenia $1.43B AUM 39.24% 1-Year Est. Return
APCM
Alaska Permanent Capital Management Anchorage, Alaska $1.43B AUM 13.12% 1-Year Est. Return
CCM
Callodine Capital Management Boston, Massachusetts $1.43B AUM 8.74% 1-Year Est. Return
KCMH
Kontiki Capital Management (HK) Hong Kong $1.43B AUM 9.81% 1-Year Est. Return
PPC
Park Presidio Capital San Francisco, California $1.43B AUM 21.33% 1-Year Est. Return
SC
Styrax Capital New York $1.43B AUM 50.63% 1-Year Est. Return

Stonebridge Capital Advisors's Q2 2017 Portfolio in Review

As of Q2 2017, Stonebridge Capital Advisors held 169 positions worth $381M, up 3.7% from $367M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Stonebridge Capital Advisors's Q2 2017 filing shows 8 new, 78 increased, 44 reduced and 5 closed positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,604 shares worth $388K. The largest sale was Unilever NV New York Registry Shares, an estimated $3.99M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Stonebridge Capital Advisors's largest Q2 2017 buy was State Street SPDR S&P 500 ETF Trust: 1,604 shares worth $388K.
  • Stonebridge Capital Advisors added most to Gilead Sciences in Q2 2017, an estimated $3.56M increase.
  • Stonebridge Capital Advisors's biggest Q2 2017 reduction was Apple, cutting an estimated $1.24M.
  • Stonebridge Capital Advisors fully exited Unilever NV New York Registry Shares in Q2 2017, selling an estimated $3.99M.
  • Stonebridge Capital Advisors's ten largest holdings make up 24% of its $381M portfolio in Q2 2017.
  • Stonebridge Capital Advisors opened 8 new positions and closed 5 in Q2 2017.
  • Stonebridge Capital Advisors's portfolio value rose 3.7% quarter-over-quarter to $381M.

Based on Stonebridge Capital Advisors's 13F filing for Q2 2017, filed 15 Aug 2017.